白血病·淋巴瘤
白血病·淋巴瘤
백혈병·림파류
Journal of Leukemia & Lymphoma
2015年
9期
513-516,521
,共5页
白血病,淋巴细胞,慢性%新药%国际淋巴瘤大会
白血病,淋巴細胞,慢性%新藥%國際淋巴瘤大會
백혈병,림파세포,만성%신약%국제림파류대회
Leukemia,lymphocytic,chronic%New agent%International Conference on Malignant lymphoma
第13届国际淋巴瘤大会(ICML)于2015年6月17日至20日在瑞士卢加诺召开.由于近几年慢性淋巴细胞白血病治疗研究方面获得了较大进展,尤其是2014年,美国及欧洲批准了4种治疗慢性淋巴细胞白血病的新药,因此关于慢性淋巴细胞白血病的议题备受关注.文章就第13届ICML报告的慢性淋巴细胞白血病的最近进展进行介绍.
第13屆國際淋巴瘤大會(ICML)于2015年6月17日至20日在瑞士盧加諾召開.由于近幾年慢性淋巴細胞白血病治療研究方麵穫得瞭較大進展,尤其是2014年,美國及歐洲批準瞭4種治療慢性淋巴細胞白血病的新藥,因此關于慢性淋巴細胞白血病的議題備受關註.文章就第13屆ICML報告的慢性淋巴細胞白血病的最近進展進行介紹.
제13계국제림파류대회(ICML)우2015년6월17일지20일재서사로가낙소개.유우근궤년만성림파세포백혈병치료연구방면획득료교대진전,우기시2014년,미국급구주비준료4충치료만성림파세포백혈병적신약,인차관우만성림파세포백혈병적의제비수관주.문장취제13계ICML보고적만성림파세포백혈병적최근진전진행개소.
The 13th International Conference on Malignant Lymphoma (ICMC) was held in Lugano, Switzerland from June 17 to 20, 2015.There was the enormous progress in the treatment of chronic lymphocytic leukemia in the past years, especially in 2014, 4 new agents for the treatment of chronic lymphocytic leukemia were approved in USA and Europe, which caused great attention on the issue of chronic lymphocytic leukemia.The latest progress of chronic lymphocytic leukemia reported at the conference was briefly introduced in this paper.
